2019.02.05PDF( 48KB)
Hisamitsu Pharmaceutical and Kyowa Hakko Kirin sign Commercialization Agreement for HP-3000, a Potential New Transdermal Patch for Parkinson's Disease in Japan
2019.01.11
FY02/2019 Q3 Results Earnings Release Presentation
2018.12.17PDF(108KB)
Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.
2018.12.14PDF(110KB)
Notification of the results of Phase III clinical study in opioid analgesic naive patients of the transdermal, pain management patch FENTOS®TAPE (development code:HFT-290)
2018.11.28PDF( 94KB)
Notification of listing on the NHI drug price standard and marketing of a new dose "0.5 mg" of 'Fentos®Tape (Development code: HFT-290)' ,Transdermal, Pain management patch